Scienion, Genomica Partner to Market Multiplexed Molecular Testing Platform | GenomeWeb

Scienion and Genomica will now offer their combined array-based testing platform to third parties, the firms said this week.

The new offering pairs Berlin-based Scienion's non-contact arraying and surface technologies with Madrid-based Genomica's multiplex PCR and microarray detection capabilities. The two companies hope that other firms will take advantage of those resources to develop new applications, including in vitro diagnostics.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.